Calithera Biosciences, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2013 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Calithera Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2013 to Q4 2022.
  • Calithera Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2022 was -$6.94M, a 90% increase year-over-year.
  • Calithera Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2022 was -$39.7M, a 65.5% increase year-over-year.
  • Calithera Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$39.7M, a 65.5% increase from 2021.
  • Calithera Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$115M, a 27.7% decline from 2020.
  • Calithera Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$90.1M, a 0.31% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 -$39.7M -$6.94M +$62.3M +90% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 -$102M -$9.8M +$1.37M +12.3% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$103M -$9.08M +$5.23M +36.6% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-16
Q1 2022 -$109M -$13.8M +$6.56M +32.2% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q4 2021 -$115M -$69.2M -$46.6M -207% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$68.4M -$11.2M +$11.6M +50.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$80M -$14.3M +$6.08M +29.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-16
Q1 2021 -$86.1M -$20.4M +$4.05M +16.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$90.1M -$22.6M -$838K -3.86% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-31
Q3 2020 -$89.3M -$22.7M -$2.44M -12% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$86.9M -$20.4M +$3.76M +15.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$90.6M -$24.4M -$759K -3.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$89.9M -$21.7M -$2.23M -11.4% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-11
Q3 2019 -$87.6M -$20.3M -$1.44M -7.66% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$86.2M -$24.2M -$21.1M -685% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$65.1M -$23.7M -$10.5M -79.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$54.6M -$19.5M -$8.53M -77.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-11
Q3 2018 -$46.1M -$18.8M -$12.8M -210% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-11
Q2 2018 -$33.3M -$3.08M +$2.12M +40.8% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-11
Q1 2018 -$35.4M -$13.2M -$7.62M -136% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-11
Q4 2017 -$27.8M -$11M -$1.45M -15.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$26.4M -$6.07M +$2.47M +28.9% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-07
Q2 2017 -$28.8M -$5.19M +$5.16M +49.9% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-07
Q1 2017 -$34M -$5.59M +$4M +41.7% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-07
Q4 2016 -$38M -$9.52M -$1.45M -18% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$36.6M -$8.54M +$356K +4% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-08
Q2 2016 -$36.9M -$10.4M -$2.54M -32.5% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-08
Q1 2016 -$34.4M -$9.58M -$1.72M -21.9% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-08
Q4 2015 -$32.6M -$8.07M -$1.24M -18.1% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$31.4M -$8.9M -$3.66M -69.9% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-16
Q2 2015 -$27.7M -$7.82M -$2.33M -42.4% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-16
Q1 2015 -$25.4M -$7.86M -$3.71M -89.4% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-16
Q4 2014 -$21.7M -$6.83M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$5.24M -$1.92M -57.9% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-15
Q2 2014 -$5.49M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-15
Q1 2014 -$4.15M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-15
Q3 2013 -$3.32M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.